FDA Releases Alexion Pharmaceuticals Inc. (ALXN) Response to 483 Report
5/9/2013 7:47:02 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
In a rare move, the FDA has publically released Alexion Pharmaceuticals’ response to a Form 483 following inspection of its US site and the discovery of microbial contamination.
Help employers find you! Check out all the jobs and post your resume.